Mayo Clinic and Illumina Collaborative Early Stage Ovarian Cancer (ESOC) Study
Demographics (1)
- age at diagnostic - Age at diagnostic (phv00225743.v1.p1)
Disease Events (26)
- AFFECTION_STATUS - Case control status of the subject (phv00225735.v1.p1)
- ANALYTE_TYPE - Analyte type (phv00225791.v1.p1)
- ca125l1 - First CA125 measurement value (phv00225776.v1.p1)
- ca125l2 - Second CA125 measurement value (phv00225778.v1.p1)
- ca125l3 - Third CA125 measurement value (phv00225780.v1.p1)
- ca125l4 - Fourth CA125 measurement value (phv00225782.v1.p1)
- causedeath - Cause of death, if dead. (phv00225749.v1.p1)
- grade - Initial stage of tumor (phv00225742.v1.p1)
- grade_final - Grade, after final post-surgery pathological review (phv00225747.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00225793.v1.p1)
- IS_TUMOR - Tumor status (phv00225792.v1.p1)
- malignancytype - Type of malignancy (phv00225744.v1.p1)
- morphlogy - Morphology of tumor (phv00225740.v1.p1)
- ned - No evidence of disease (NED) or remission (phv00225750.v1.p1)
- recur - Recurrence (phv00225751.v1.p1)
- stage - Stage of tumor (phv00225741.v1.p1)
- stage_final - Stage, after final post-surgery pathological review (phv00225745.v1.p1)
- substage final - Sub-stage, after final post-surgery pathological review (phv00225746.v1.p1)
- t_dxdead_mth - Time from diagnostic to death (months) (phv00225756.v1.p1)
- t_dxrec_mth - Time from diagnostic to recurrence (months) (phv00225753.v1.p1)
- tumorsite - Tumor site (phv00225759.v1.p1)
- typesrg1 - Type of surgery 1 (phv00225771.v1.p1)
- typesrg2 - Type of surgery 2 (phv00225772.v1.p1)
- typesrg3 - Type of surgery 3 (phv00225773.v1.p1)
- typesrg4 - Type of surgery 4 (phv00225774.v1.p1)
- vital_status - Whether the patient is alive or dead at date of last follow-up (phv00225748.v1.p1)
Medications (4)
- chemdrg1 - Chemotherapy drugs regimen 1 (phv00225785.v1.p1)
- chemdrg2 - Chemotherapy drugs regimen 2 (phv00225786.v1.p1)
- cyclesdrug1 - Number of cycles of chemotherapy regimen 1 (phv00225787.v1.p1)
- cyclesdrug2 - Number of cycles of chemotherapy regimen 2 (phv00225788.v1.p1)
Other (32)
- ASCITES - Whether fluids were present in the peritoneal cavity (ascites) (phv00225760.v1.p1)
- ascitesvol - Volume of ascites (phv00225761.v1.p1)
- ascitesvolkn - Whether the volume of ascites is known (if present) (phv00225762.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00225790.v1.p1)
- ca125dt1_mth - First CA125 measurement date (months) (phv00225775.v1.p1)
- ca125dt2_mth - Second CA125 measurement date (months) (phv00225777.v1.p1)
- ca125dt3_mth - Third CA125 measurement date (months) (phv00225779.v1.p1)
- ca125dt4_mth - Fourth CA125 measurement date (months) (phv00225781.v1.p1)
- chemoloc - Institution where chemotherapy was administered (phv00225783.v1.p1)
- clinicaltrialyn - Clinical trial (phv00225784.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00225732.v1.p1)
- DEBULKIN - Whether debulking was optimal or partial (phv00225763.v1.p1)
- debulkperct - Percent debulking (phv00225765.v1.p1)
- debulkperctkn - Whether percent debulking is known (phv00225764.v1.p1)
- PERICYTO - Peritoneal wash cytology (phv00225766.v1.p1)
- recursource - Source of recurrence information (phv00225752.v1.p1)
- residual - Are there visible residual tumor left after debulking (phv00225767.v1.p1)
- residualdiakn - Whether the diameter of residual tumors is known (phv00225768.v1.p1)
- residualdiamm - Residual diameter of residual tumors (phv00225769.v1.p1)
- SAMPLE_ID - De-identified sample ID (phv00225789.v1.p1)
- SAMPLE_ID - Sample ID (phv00225737.v1.p1)
- SAMPLE_USE - Sample use. Array_CNV: CNV genotypes obtained using standard or custom microarrays; Array_SNP: SNP genotypes obtained using standard or custom microarrays; Seq_DNA_CNV: CNV genotypes derived from sequence data; Seq_DNA_SNP: SNP genotypes derived from sequence data; Seq_DNA_WholeGenome: Whole genome sequencing; Seq_RNA_WTSS: Whole transcriptome shotgun sequencing (RNA-seq) (phv00225738.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00225734.v1.p1)
- SUBJECT_ID - De-identified subject ID (phv00225739.v1.p1)
- SUBJECT_ID - Subject ID (phv00225731.v1.p1)
- SUBJECT_ID - Subject ID (phv00225736.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00225733.v1.p1)
- surg_months - Months between surgery and initial diagnostic (phv00225770.v1.p1)
- surgloc - Institution where surgery was performed. (phv00225757.v1.p1)
- surgoccur - Whether this was a surgery for a primary cancer. (phv00225758.v1.p1)
- t_dxeval_mth - Time from diagnostic to last evaluation (months) (phv00225754.v1.p1)
- t_fu_mth - Time from diagnostic to last follow-up (months) (phv00225755.v1.p1)